&w=3840&q=100)
Aerospace & defence stock up 86% so far in June; zooms 146% from May low
Deepak Korgaonkar Mumbai
Share price of SIKA Interplant Systems today: Shares of Sika Interplant Systems (SIKA) hit a new high of ₹1,537.30, as the scrip surged 10 per cent on the BSE in Wednesday's intra-day trade on healthy business outlook.
Thus far in June, the stock price of this aerospace & defence (A&D) company has soared 87 per cent. It has more than doubled or zoomed 146 per cent from its previous month low of ₹626.10 touched on May 7, 2025. It has skyrocketed 195 per cent from its May month low of ₹520.30 on the BSE.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
an hour ago
- Mint
Mukul Agarwal portfolio: Ace investor slashes stakes in these 2 stocks in Q1
Mukul Agarwal portfolio: Renowned investor Mukul Mahavir Agrawal, who is also known as Warren Buffet of India, has trimmed his holdings in two smallcap companies—Sula Vineyards and Raghav Productivity Enhancers—during the quarter ending June 30, 2025. According to data available at trendlyne, Mukul Agarwal publicly holds 62 stocks with a net worth of over ₹ 6,733.6 crore. Agrawal included the SME stock Monolithisch India in his portfolio during the quarter ending in June, purchasing 5 lakh shares, which account for a 2.30 per cent stake in the company. Additionally, he acquired a 1.27 per cent stake in Jammu & Kashmir Bank, expanding his holdings in the state-owned lender. According to the data available on BSE , the ace investor has reduced his stake from 2.19 per cent to 1.78 per cent in the June quarter 2025. Agarwal now holds 15,00,000 shares in the small-cap stock. Agrawal's decision to reduce his stake in Sula Vineyards comes against the backdrop of the stock's prolonged underperformance. Over the past year, its value has dropped by 40 per cent, including a 28 per cent decline in 2025 alone. Agarwal has cut his stake in Raghav Productivity Enhancers from 1.55 per cent in March quarter to 1.04 per cent in June quarter. As per the BSE data, the ace investors currently holds 4,78,000 shares in the small-cap company. It seems like Agrawal has taken some profits off the table in Raghav Productivity following a sharp uptrend. The stock has surged 40 per cent in the last 12 months, significantly outperforming the Nifty, which has gained just 2 per cent during the same timeframe. Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions.
&w=3840&q=100)
Business Standard
an hour ago
- Business Standard
Intuitional buyers drive demand for Anthem Biosciences IPO; GMP up 26%
Anthem Biosciences IPO subscription status: Non-institutional investors (NIIs) were driving the demand for the initial public offering (IPO) of Anthem Biosciences on the final day of subscription. The participation from the qualified institutional buyers (QIBs), and retail investors was also encouraging as the public issue garnered bids for 48,76,15,180 equity shares against 4,40,70,682 on offer, resulting in an oversubscription of 11:06 times till 12:42 PM on Wednesday, July 16, showed the NSE data. Among the individual categories, NIIs have oversubscribed the category reserved for them by 27.08 times, followed by QIBs at 11.86 times, and retail investors at 3.80 imes. Anthem Biosciences IPO grey market premium (GMP) today The favourable sentiments were seen in the grey markets too, where the company's unlisted shares were exchanging hands at around ₹720 apiece, reflecting a grey market premium (GMP) of ₹150 per share or approximately 26.32 per cent above the upper end of the IPO price band of ₹570 apiece, according to the sources tracking grey market activities. Anthem Biosciences IPO review Analysts at Anand Rathi Research have assigned a subscribe rating to the issue, citing the company's potential to continue to grow its revenue and profitability ratios compared to its peers. Those at SBI Securities have recommended the investors to subscribe to the public issue for the long-term perspective, citing that the IPO is fairly priced while comparing with peers, along with a superior return and margin profile. Anthem Biosciences IPO details The ₹3,395.00 crore public issue of Anthem Biosciences comprises an entirely offer for sale (OFS) with promoters and shareholders divesting 59.6 million equity shares. The public issue is being offered in a price band of ₹540-570 per share, with a lot size of 26 shares. A retail investor can bid for a minimum of 1 lot or 26 and in multiples thereof, with a minimum investment of ₹14,820. As the subscription window closed today, the basis of allotment of Anthem Biosciences IPO shares is expected to be finalised on July 17, with shares credited to successful applicants' demat accounts on July 18. Anthem Biosciences shares are scheduled to list on the NSE and BSE tentatively on July 21, 2025. Kfin Technologies is acting as the registrar to the issue, while JM Financial is serving as the sole book-running lead manager. About Anthem Biosciences Anthem Biosciences is an innovation-led CRDMO (Contract Research Development and Manufacturing Organization) in India, offering end-to-end services across drug discovery, development, and manufacturing for both New Chemical Entity (NCE) and New Biological Entity (NBE). The company is among a select group of Indian players with integrated capabilities spanning New Chemical Entities (NCEs) and New Biological Entities (NBEs) across the drug discovery, development, and commercial manufacturing value chain.
Mint
an hour ago
- Mint
Small-cap stock under ₹20 skyrockets over 13% after Q1 results outcome
Stock Market Today: Small-cap stock under ₹ 20 skyrocketed over 13% during the intraday trades on Wednesday after the Q1 results outcome. Check details about Hathway Cable & Datacom Ltd In Q1 FY26, consolidated net profit for Hathway Cables saw a sharp 69% rise to ₹ 31.03 crore compared to ₹ 18.37 crore in the year-ago quarter. The strong jump in net profit during the April-June 2025 quarter was driven by a sharp improvement in the operating performance. The profit before tax at ₹ 40.28 crore during the April-June quarter of 2025 grew close to 60% compared to ₹ 25.29 crore in the April-June 2024 quarter. The revenue from operations was ₹ 530.50 crore, a 5.55% year-on-year increase compared to ₹ 502.61 during the April-June 2024 quarter. Small-cap stock under ₹ 20, Hathway Cable & Datacom share price movement Hathway Cable & Datacom share price opened at ₹ 16.10 on the BSE on Wednesday. The Hathway Cable & Datacom share price at the time of opening was more than 2% higher than the previous trading session's closing price of ₹ 15.77. However, the Hathway Cable & Datacom share price gained to intraday highs of ₹ 17.95, which meant gains of more than 13% (13.8%) during the intraday trades on Wednesday. Hathway Cable & Datacom share price had scaled to a 52-week, or 1-year, high of ₹ 25.66 in July last year. However, the Hathway Cable & Datacom share price had seen significant correction thereafter to 52-week or 1-year lows of ₹ 11.94 in April this year, following sharp correction in the Indian Stock Markets amidst valuation concerns and global uncertainties. led by geopolitical tensions and also the tariff-related concerns Hathway Cable & Datacom share price thereafter has rebounded well from lows in April. Disclaimer: The views and recommendations made above are those of individual analysts or brokerage companies and not of Mint. We advise investors to check with certified experts before making any investment decisions
